ICR
Clinical Trial Results Support Liquid Biopsy Monitoring to Predict Responders to Palbociclib
Premium
A study reported this week that measuring changes in the numbers of specific circulating tumor DNA mutations can rapidly identify breast cancer patients who will have better outcomes.
Landscape Still Unclear for Prostate Cancer Therapy Prediction Tests as New Approaches Emerge
Premium
New data points to strong predictive ability for a ddPCR-based test of AR copy number, while other companies are pursuing tests that target expression of AR splice variants.